AMA: Trump administration requiring pricing information in TV drug ads

| 2 Min Read

Statement attributable to:

Barbara L. McAneny, MD 

President, American Medical Association

“The Trump Administration has taken a step in the right direction by requiring pricing information in direct-to-consumer television advertising of prescription drugs. Last year, the AMA called for regulations requiring the ads to include the manufacturer’s list price of those drugs, and we have supported similar legislative efforts. This small dose of transparency will help patients have a more complete picture when faced with prescription drug ads. 

 

Full press statement available when you sign in

Sign in to the AMA website to get the full version of this press statement. 

AMA membership has its advantages

  • Be a part of the nation's largest physician organization
  • Play a role in shaping the future of health care
  • Enjoy exclusive perks and savings

Not a member? Become a member now.

 

FEATURED STORIES

Smiling woman embraces another

4 huge Medicare pay reforms are part of new bipartisan House bill

| 5 Min Read
Eyeball with target

AMA takes fight to Wisconsin optometrists performing eye surgeries

| 5 Min Read
Baby with bandage on upper thigh

Measles is spreading. Vaccination remains our best defense.

| 4 Min Read
Figure stands with giant pencil and checklist

How to know it is time to apply for AMA Joy in Medicine recognition

| 7 Min Read